Global surgical robotics company, CMR Surgical (CMR), has received regulatory approval for the Versius® Surgical Robotic System from the Brazilian Health Regulatory Agency, Anvisa, paving the way for commercialisation in the high growth Brazilian surgical robotics market.
Brazil is a strategically important market for CMR, where robotic assisted surgery is considered a key innovation for surgical practice. With significant growth in surgical robotic procedures in Brazil, there is strong potential for CMR to play a key role in further shaping surgical practice in the coming years, with Versius offering a versatile new choice for hospitals and supporting optimal patient outcomes.
With the approval, CMR is set to further expand its global presence, offering innovative surgical robotic technology in Brazil and more widely across Latin America where other countries are typically influenced by regulatory developments in Brazil. Versius is already used as a valuable tool by hospitals across the world in Europe, Australia, India and the Middle East.
Per Vegard Nerseth, Chief Executive Officer, CMR Surgical, commented: “This regulatory approval has enabled us to move forward with preparations for a rapid launch of Versius in Brazil, bringing our new-generation technology that can benefit surgeons and patients immensely. Versius can help expand access to robotic assisted surgery and offer an affordable option for hospitals, contributing to significant savings for Brazil’s healthcare system. Important achievements in countries like Brazil enable us to continue great momentum for Versius globally, representing another important milestone in our work to enable many more people around the world to access minimal access surgery.”
Dr. Carlos Eduardo Domene, Head of Robotics, Rede D’Or Hospital Group, São Paulo, commented: “Brazil is a country that is highly open to innovation in healthcare. When we observe the evolution of technology systems to carry out manually demanding, complex procedures such as robotic assisted surgery, we see substantial benefits for patients and surgeons. It is great to see Anvisa recognising advanced technology that will increase access to more patients awaiting surgery and, importantly, address barriers for surgeons performing physically demanding manual procedures in surgeries.”
“Versius is already used by surgeons worldwide in different surgical specialties and we anticipate strong demand for Versius in Brazil. The small, modular design makes Versius highly versatile and ideal for high utilisation in operating rooms. Flexible financial options to suit hospitals wishing to use Versius as part of value-based healthcare solutions are also available, offering hospitals access to a more complete portfolio of the latest and most advanced technology for robotic assisted surgery” explains Marcio C Coelho, Head of Operations LatAm, CMR Surgical. “We look forward to working alongside our partners in collaboration to bring transformative surgical robotic technology for many more patients across LatAm.”
Source: CMR Surgical.